Benzinga | Nov 6, 2020 06:40AM EST

HC Wainwright & Co. Maintains Neutral on Sage Therapeutics, Raises Price Target to $81

HC Wainwright & Co. maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and raises the price target from $76 to $81.